Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6NYB

Structure of a MAPK pathway complex

Summary for 6NYB
Entry DOI10.2210/pdb6nyb/pdb
EMDB information0541
DescriptorSerine/threonine-protein kinase B-raf, Dual specificity mitogen-activated protein kinase kinase 1, 14-3-3 protein zeta, ... (8 entities in total)
Functional Keywordstransferase
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains4
Total formula weight193116.14
Authors
Park, E.,Rawson, S.,Li, K.,Jeon, H.,Eck, M.J. (deposition date: 2019-02-11, release date: 2019-10-09, Last modification date: 2024-10-23)
Primary citationPark, E.,Rawson, S.,Li, K.,Kim, B.W.,Ficarro, S.B.,Pino, G.G.,Sharif, H.,Marto, J.A.,Jeon, H.,Eck, M.J.
Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes.
Nature, 575:545-550, 2019
Cited by
PubMed Abstract: RAF family kinases are RAS-activated switches that initiate signalling through the MAP kinase cascade to control cellular proliferation, differentiation and survival. RAF activity is tightly regulated and inappropriate activation is a frequent cause of cancer; however, the structural basis for RAF regulation is poorly understood at present. Here we use cryo-electron microscopy to determine autoinhibited and active-state structures of full-length BRAF in complexes with MEK1 and a 14-3-3 dimer. The reconstruction reveals an inactive BRAF-MEK1 complex restrained in a cradle formed by the 14-3-3 dimer, which binds the phosphorylated S365 and S729 sites that flank the BRAF kinase domain. The BRAF cysteine-rich domain occupies a central position that stabilizes this assembly, but the adjacent RAS-binding domain is poorly ordered and peripheral. The 14-3-3 cradle maintains autoinhibition by sequestering the membrane-binding cysteine-rich domain and blocking dimerization of the BRAF kinase domain. In the active state, these inhibitory interactions are released and a single 14-3-3 dimer rearranges to bridge the C-terminal pS729 binding sites of two BRAFs, which drives the formation of an active, back-to-back BRAF dimer. Our structural snapshots provide a foundation for understanding normal RAF regulation and its mutational disruption in cancer and developmental syndromes.
PubMed: 31581174
DOI: 10.1038/s41586-019-1660-y
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (4.1 Å)
Structure validation

235666

PDB entries from 2025-05-07

PDB statisticsPDBj update infoContact PDBjnumon